{
    "general_params": {
        "compounds": [
            {
                "pubchem_id": 156935,
                "compound": "cosmomycin",
                "mol_mass": 771.347,
                "molecular_formula": "C40H53NO14",
                "chem_struct": "CC[C@]1(CCC2=C(C3=C(C(=C2[C@H]1O[C@H]4C[C@@H]([C@@H]([C@@H](O4)C)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6CC[C@@H]([C@@H](O6)C)O)O)N(C)C)O)C(=O)C7=C(C3=O)C(=CC=C7)O)O)O",
                "chem_synonyms": [
                    "Rhodilunacin B",
                    "Cosmomycin B",
                    "Rhodomycin Y",
                    "Rhodilunanencin B",
                    "Retamycin E 2",
                    "gamma-Rhodomycin Y",
                    "gamma-Rhodomycin RDRS",
                    "77517-27-2",
                    "5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-ethyl-1,6,8,11-tetrahydroxy-7-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-((2S-(2-alpha,5-beta,6-beta))-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-alpha-L-lyxo-hexopyranosyl)-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (7R-trans)-",
                    "Retamycin E2",
                    "AC1L4H2T",
                    "DTXSID80228220",
                    "40795-73-1",
                    "LS-94105",
                    "LS-143712",
                    "(9R,10R)-10-[(2S,4S,5S,6S)-4-(dimethylamino)-5-[(2S,4S,5S,6S)-4-hydroxy-5-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-9-ethyl-4,6,9,11-tetrahydroxy-8,10-dihydro-7H-tetracene-5,12-dione",
                    ""
                ]
            }
        ],
        "loci": {
            "accession": "DQ280500.1",
            "conn_comp_cluster": [
                "Unknown"
            ],
            "complete": "Unknown"
        },
        "mibig_accession": "BGC0000214",
        "publications": [
            "pubmed:16810496"
        ],
        "minimal": true,
        "biosyn_class": [
            "Polyketide"
        ],
        "polyketide": {
            "pks_subclass": [
                "Type II"
            ]
        }
    },
    "personal": {
        "submitter_name": "mibig.secondarymetabolites.org",
        "submitter_institution": "MIBiG",
        "submitter_email": "info@mibig.secondarymetabolites.org"
    },
    "changelogs": [
        {
            "version": "2.0",
            "comment": "Submitted"
        }
    ]
}